Department of Genetics, School of Ecology and Conservation Genetics, GKVK Campus, University of Agricultural Science, Bangalore-560 065, Karnataka, India.
Eur J Pharmacol. 2010 Apr 10;631(1-3):42-52. doi: 10.1016/j.ejphar.2009.12.034. Epub 2010 Jan 11.
Grewia tiliaefolia is widely used in traditional Indian medicines to cure jaundice, biliousness, dysentery and the diseases of blood. Bioassay-guided fractionation of methanolic extract of the G. tiliaefolia bark has resulted in the isolation of D-erythro-2-hexenoic acid gamma-lactone (EHGL) and gulonic acid gamma-lactone (GAGL). Hepatoprotective activity of the methanolic extract and the isolated constituents were evaluated against CCl(4)-induced hepatotoxicity in rats. The treatment with methanolic extract, EHGL and GAGL at oral doses of 100, 150 and 60 mg/kg respectively with concomitant CCl(4) intraperitoneal injection (1 ml/kg) significantly reduced the elevated plasma levels of aminotransferases, alkaline phosphatase and the incidence of liver necrosis compared with the CCl(4)-injected group without affecting the concentrations of serum bilirubin and hepatic markers. EHGL and GAGL significantly inhibited the elevated levels of thiobarbituric acid reactive substances and glutathione in liver homogenates. Histology of the liver tissues of the extract and isolated constituents treated groups showed the presence of normal hepatic cords, absence of necrosis and fatty infiltration as similar to the normal control. The results revealed that the hepatoprotective activity of EHGL is significant as similar to the standard drug silymarin. To clarify the influence of the extract and isolated constituents on the protection of oxidative-hepatic damage, we examined in vitro antioxidant properties of the test compounds. The extract and the constituents showed significant free radical scavenging activity. These results suggest that the extract as well as the constituents could protect the hepatocytes from CCl(4)-induced liver damage perhaps, by their anti-oxidative effect on hepatocytes, hence eliminating the deleterious effects of toxic metabolites from CCl(4).
五桠果在传统的印度药物中被广泛用于治疗黄疸、胆汁、痢疾和血液疾病。对五桠果树皮的甲醇提取物进行生物测定指导的分段分离,得到 D-erythro-2-hexenoic acid gamma-lactone (EHGL) 和 gulonic acid gamma-lactone (GAGL)。用 CCl(4)腹腔注射(1ml/kg)对大鼠进行肝毒性试验,评价甲醇提取物和分离成分的肝保护活性。与 CCl(4)注射组相比,100、150 和 60mg/kg 口服剂量的甲醇提取物、EHGL 和 GAGL 分别与 CCl(4)同时腹腔注射(1ml/kg)可显著降低升高的血浆转氨酶、碱性磷酸酶水平和肝坏死发生率,而不影响血清胆红素和肝标志物的浓度。EHGL 和 GAGL 显著抑制肝匀浆中升高的硫代巴比妥酸反应物质和谷胱甘肽水平。提取物和分离成分治疗组的肝组织学显示,正常肝索存在,无坏死和脂肪浸润,类似于正常对照组。结果表明,EHGL 的肝保护活性与标准药物水飞蓟素相似。为了阐明提取物和分离成分对氧化肝损伤保护的影响,我们检查了测试化合物的体外抗氧化性能。提取物和成分显示出显著的自由基清除活性。这些结果表明,提取物和成分可以通过其对肝细胞的抗氧化作用来保护肝细胞免受 CCl(4)诱导的肝损伤,从而消除 CCl(4)毒性代谢物的有害影响。